CollPlant Biotechnologies
CLGN
CLGN
17 hedge funds and large institutions have $9.14M invested in CollPlant Biotechnologies in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 18 → 17 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
17
Holding in Top 10
1
Calls
$12K
Puts
$11K
Top Buyers
| 1 | +$391K | |
| 2 | +$43K | |
| 3 | +$32.5K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.37K |
Top Sellers
| 1 | -$928K | |
| 2 | -$65.2K | |
| 3 | -$54.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$31.7K |
| 5 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$4.22K |